Proxima

Join us in Seoul on Tuesday, July 7th for an evening social hosted by Proxima, NVIDIA Healthcare, DCVC and Terray Therapeutics. Enjoy an open bar, bites, and a curated group of researchers, founders, and investors at the intersection of AI x Bio. Spots are limited. RSVP here: https://luma.com/2g1rr4v6

Discovering proximity-based medicines means connecting many disciplines such as foundation model training, chemistry, biology, and proteomics. Powered by the NVIDIA BioNeMo Agent Toolkit, our AI agents tie these domains together, turning new biology into therapeutic hypotheses faster and moving promising programs toward patients sooner. We're proud to build that future alongside NVIDIA Healthcare as they launch the BioNeMo Agent Toolkit at BIO 2026. Links: - BioNeMo Agent Toolkit GitHub Repo: https://bit.ly/43Qp8ja - Blogpost: https://bit.ly/4vssVPG

Proxima is teaming up with NVIDIA for NYC Tech Week. Join us Thursday, June 4 from 7-11 PM in Manhattan an evening of conversation with founders, scientists, builders, and investors across AI x Bio. Open bar, small plates, and music. RSVP below - very limited spots!  https://luma.com/atqd9q0g NVIDIA Healthcare

Proxima is teaming up with NVIDIA for NYC Tech Week. Join us Thursday, June 4 from 7-11 PM in Manhattan an evening of conversation with founders, scientists, builders, and investors across AI x Bio. Open bar, small plates, and music. RSVP below - very limited spots!  https://luma.com/atqd9q0g NVIDIA Healthcare

The Proxima team is thrilled to be at ICLR 2026 in Rio! We're hiring Researchers and we'll be at ICLR to meet in person. If you're pushing the boundaries of generative AI x Bio, we want to talk. Apply here and we will be in touch to schedule: https://bit.ly/4cihNOs

Join us for an evening social at ICLR, hosted by Proxima and NVIDIA Healthcare Rooftop bar, bites, and a curated room of researchers, founders, and engineers at the intersection of AI x Bio. Spots are limited. RSVP here: https://luma.com/AIxBio

Drug discovery has a scale problem. The complexes that govern signaling, regulation, and disease aren't single proteins, or even tidy pairs. They're sprawling assemblies of 10, 20, even 50+ subunits. The field is forced to sidestep that level of complexity, not for lack of interest, but for lack of tools. And yet, simulating cellular biology requires modeling the complexes and interactions these proteins form, not just individual proteins. NeoLink, Proxima's proteomics platform, has experimentally mapped millions of protein-protein interactions across these higher-order complexes. Predicting their structures at this scale demanded something new. We built it with NVIDIA Healthcare. By integrating NVIDIA's Fold-CP into our pipeline, we distribute computation for long biological sequences across multiple GPUs, removing the memory bottleneck that kept these complexes out of reach. New preprint out now with the NVIDIA BioNeMo team: https://bit.ly/4rDQnXA

We are adding world-class expertise to our Scientific Advisory Board at Proxima: Dr. Ray Deshaies, Ph.D.: co-inventor of PROTACs, National Academy of Sciences member, fmr SVP Global Research at Amgen Dr. Lyn Jones: molecular glue leader, fmr Head of Chemical Biology at Pfizer, PI at Dana-Farber Dr. Juri Rappsilber: pioneer of cross-linking mass spectrometry, Chair of Bioanalytics at TU Berlin We're excited to tap their deep expertise in target biology, medicinal chemistry, and structural proteomics as we build the platform for rational design of proximity-based medicines. Press release: https://bit.ly/4d4dYwV

Thrilled to have DCVC and NVIDIA alongside us as we build the platform for proximity-based medicines. We're just getting started: multiple exciting announcements coming soon. If you want to work on frontier ML models and an unprecedented biological data generation engine, we'd love to hear from you: recruiting@proximabio.com

Excited to announce that our team at Proxima (formerly VantAI) has raised $80M led by DCVC with participation from NVIDIA, Braidwell, Roivant, AIX Ventures, Yosemite, Magnetic Ventures, Alexandria Real Estate Equities, Inc., Modi Ventures, and others. This funding accelerates our mission to build the platform for proximity-based medicines - molecular glues, PROTACs, and the next generation of therapeutics targeting the vast majority of protein interactions that remain structurally uncharted. Links: Bloomberg Exclusive: https://bit.ly/3LaM1Iw Press Release: https://bit.ly/4jJG6qI Website: https://proximabio.com/